Print

CBD Oil Research

At this time, the Food & Drug Administration (FDA) has only approved CBD oil for epilepsy in children. It is inappropriate to make any health claims about CBD Oil until further studies have been done.

https://www.ncbi.nlm.nih.gov/pmc/?term=cbd


Review of the neurological benefits of phytocannabinoids

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5938896/

Results: 

ConclusionAlthough federal and state laws are inconsistent about the legality of cannabis production, its increasingly documented health benefits make it once again relevant in medicine. Current research indicates the phytocannabinoids have a powerful therapeutic potential in a variety of ailments primarily through their interaction with the ECS. CBD is of particular interest due to its wide-ranging capabilities and lack of side effects in a variety of neurological conditions and diseases.

tabled

Mecha M, Feliú A, Carrillo-Salinas F, Guaza C. Handbook of Cannabis and Related Pathologies. Elsevier; 2017. pp. 893–904.


Translational Investigation of the Therapeutic Potential of Cannabidiol (CBD): Toward a New Age

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6161644/


Transdermal cannabidiol reduces inflammation and pain-related behaviours in a rat model of arthritis

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4851925/

Conclusions: These data indicate that topical CBD application has therapeutic potential for relief of arthritis pain-related behaviours and inflammation without evident side-effects.


Cannabidiol in Humans—The Quest for Therapeutic Targets

Cannabidiol (CBD), a major phytocannabinoid constituent of cannabis, is attracting growing attention in medicine for its anxiolytic, antipsychotic, antiemetic and anti-inflammatory properties. However, up to this point, a comprehensive literature review of the effects of CBD in humans is lacking. 

Keywordscannabidiol, THC, cannabis, multiple sclerosis, pain, social anxiety disorder, epilepsy, insomnia, schizophrenia

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3763649/


Evidence for the efficacy and effectiveness of THC-CBD oromucosal spray in symptom management of patients with spasticity due to multiple sclerosis

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4710104/


Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes (acne)

The endocannabinoid system (ECS) regulates multiple physiological processes, including cutaneous cell growth and differentiation. Here, we explored the effects of the major nonpsychotropic phytocannabinoid of Cannabis sativa, (-)-cannabidiol (CBD), on human sebaceous gland function and determined that CBD behaves as a highly effective sebostatic agent. ... Collectively, our findings suggest that, due to the combined lipostatic, antiproliferative, and antiinflammatory effects, CBD has potential as a promising therapeutic agent for the treatment of acne vulgaris.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4151231/